ATE458498T1 - Zellwachstumshemmer mit anti-pept-antikörper - Google Patents
Zellwachstumshemmer mit anti-pept-antikörperInfo
- Publication number
- ATE458498T1 ATE458498T1 AT02788719T AT02788719T ATE458498T1 AT E458498 T1 ATE458498 T1 AT E458498T1 AT 02788719 T AT02788719 T AT 02788719T AT 02788719 T AT02788719 T AT 02788719T AT E458498 T1 ATE458498 T1 AT E458498T1
- Authority
- AT
- Austria
- Prior art keywords
- pept
- cell growth
- antibodies
- growth inhibitors
- cytotoxic activity
- Prior art date
Links
- 239000003966 growth inhibitor Substances 0.000 title abstract 2
- 230000010261 cell growth Effects 0.000 abstract 2
- 230000001472 cytotoxic effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001369608 | 2001-12-04 | ||
JP2002164834 | 2002-06-05 | ||
PCT/JP2002/012708 WO2003047621A1 (fr) | 2001-12-04 | 2002-12-04 | Inhibiteur de la proliferation cellulaire contenant un anticorps dirige contre pept |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458498T1 true ATE458498T1 (de) | 2010-03-15 |
Family
ID=26624860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02788719T ATE458498T1 (de) | 2001-12-04 | 2002-12-04 | Zellwachstumshemmer mit anti-pept-antikörper |
Country Status (7)
Country | Link |
---|---|
US (1) | US7666998B2 (de) |
EP (1) | EP1462113B1 (de) |
JP (2) | JPWO2003047621A1 (de) |
AT (1) | ATE458498T1 (de) |
AU (1) | AU2002354374A1 (de) |
DE (1) | DE60235499D1 (de) |
WO (1) | WO2003047621A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2003033024A1 (ja) * | 2001-10-16 | 2006-07-06 | 中外製薬株式会社 | 細胞増殖抑制剤 |
JPWO2003047621A1 (ja) | 2001-12-04 | 2005-04-14 | 中外製薬株式会社 | 抗PepT抗体を含有する細胞増殖抑制剤 |
WO2003083116A1 (fr) | 2002-03-29 | 2003-10-09 | Chugai Seiyaku Kabushiki Kaisha | Procede de criblage d'inhibiteurs de transporteurs |
AU2003242024A1 (en) | 2002-06-05 | 2003-12-22 | Chugai Seiyaku Kabushiki Kaisha | Method of constructing antibody |
US7731960B2 (en) | 2003-03-28 | 2010-06-08 | Chugai Seiyaku Kabushiki Kaisha | Antibodies that inhibit transport activity of peptide transporters |
JP4846569B2 (ja) | 2004-03-31 | 2011-12-28 | 中外製薬株式会社 | 抗体作製用非ヒト動物およびこれを用いた抗体作製方法およびシステム |
WO2016022821A1 (en) * | 2014-08-06 | 2016-02-11 | Georgia State University Research Foundation, Inc. | Compositions and methods for treating colorectal cancer |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108499A (en) | 1993-02-04 | 2000-02-29 | Lilly Co Eli | Mammalian influx peptide transporter |
US5500346A (en) * | 1993-06-29 | 1996-03-19 | Eli Lilly And Company | Monoclonal antibodies to human influx peptide transporter |
US5849525A (en) * | 1994-03-09 | 1998-12-15 | Brigham And Women's Hospital, Inc. | Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same |
JPH08134100A (ja) | 1994-11-09 | 1996-05-28 | Unitika Ltd | 糖鎖特異的抗体の製造方法 |
WO1997019919A1 (fr) | 1995-11-30 | 1997-06-05 | C & C Research Laboratories | Derives de sulfamides |
FR2761994B1 (fr) * | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
JPH11172A (ja) | 1997-06-11 | 1999-01-06 | Snow Brand Milk Prod Co Ltd | ペプチド輸送タンパク質遺伝子を含むdna、ベクター及び微生物 |
US6867017B1 (en) * | 1998-10-23 | 2005-03-15 | The United States Of America As Represented By The Department Of Health And Human Services | ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia |
CA2350207C (en) | 1998-11-10 | 2011-02-08 | University Of Rochester | T cells specific for target antigens and methods and vaccines based thereon |
JP4552056B2 (ja) | 1999-11-15 | 2010-09-29 | 独立行政法人科学技術振興機構 | 後天的免疫寛容の獲得方法 |
JP2001197846A (ja) | 2000-01-18 | 2001-07-24 | Ys New Technology Kenkyusho:Kk | 免疫寛容動物の作製方法 |
JPWO2003033024A1 (ja) * | 2001-10-16 | 2006-07-06 | 中外製薬株式会社 | 細胞増殖抑制剤 |
JPWO2003047621A1 (ja) | 2001-12-04 | 2005-04-14 | 中外製薬株式会社 | 抗PepT抗体を含有する細胞増殖抑制剤 |
WO2003083116A1 (fr) | 2002-03-29 | 2003-10-09 | Chugai Seiyaku Kabushiki Kaisha | Procede de criblage d'inhibiteurs de transporteurs |
AU2003242024A1 (en) * | 2002-06-05 | 2003-12-22 | Chugai Seiyaku Kabushiki Kaisha | Method of constructing antibody |
US7731960B2 (en) * | 2003-03-28 | 2010-06-08 | Chugai Seiyaku Kabushiki Kaisha | Antibodies that inhibit transport activity of peptide transporters |
JP4846569B2 (ja) | 2004-03-31 | 2011-12-28 | 中外製薬株式会社 | 抗体作製用非ヒト動物およびこれを用いた抗体作製方法およびシステム |
-
2002
- 2002-12-04 JP JP2003548876A patent/JPWO2003047621A1/ja active Pending
- 2002-12-04 AU AU2002354374A patent/AU2002354374A1/en not_active Abandoned
- 2002-12-04 AT AT02788719T patent/ATE458498T1/de not_active IP Right Cessation
- 2002-12-04 US US10/497,900 patent/US7666998B2/en not_active Expired - Fee Related
- 2002-12-04 EP EP02788719A patent/EP1462113B1/de not_active Expired - Lifetime
- 2002-12-04 DE DE60235499T patent/DE60235499D1/de not_active Expired - Lifetime
- 2002-12-04 WO PCT/JP2002/012708 patent/WO2003047621A1/ja active Application Filing
-
2009
- 2009-09-08 JP JP2009206514A patent/JP2010013471A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20050281825A1 (en) | 2005-12-22 |
DE60235499D1 (de) | 2010-04-08 |
JPWO2003047621A1 (ja) | 2005-04-14 |
EP1462113A4 (de) | 2004-12-29 |
EP1462113A1 (de) | 2004-09-29 |
WO2003047621A1 (fr) | 2003-06-12 |
JP2010013471A (ja) | 2010-01-21 |
US7666998B2 (en) | 2010-02-23 |
AU2002354374A1 (en) | 2003-06-17 |
EP1462113B1 (de) | 2010-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20074091B (en) | Cripto blocking antibodies and uses thereof | |
EA200200105A1 (ru) | СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ; | |
WO2004058171A3 (en) | Antibodies against gpr64 and uses thereof | |
GEP20105118B (en) | Anti-vegf antibodies | |
NZ595450A (en) | Antibodies to M-CSF | |
ATE381943T1 (de) | Zellwachstumsinhibition | |
NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
AU9399501A (en) | Therapeutic antibodies | |
WO2001000245A3 (en) | HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES | |
GEP20094829B (en) | Fully human antibodies against human 4-1bb (cd137) | |
MY139055A (en) | Lyophilised preparation containing antibodies to the egf receptor | |
ATE355079T1 (de) | Behandlung von prostata-krebs mit anti-erbb2 antikörpern | |
WO2001064246A3 (en) | Farnesyl protein transferase inhibitor combinations with an her2 antibody | |
EA200401345A1 (ru) | Лечение гастропареза | |
EE05140B1 (et) | Lhtematerjal tseeriumil p?hinevatele abrasiividele, selle tootmismeetod, tseeriumil p?hinevate abrasiivide tootmismeetod ja tseeriumil p?hinev abrasiiv | |
ATE458498T1 (de) | Zellwachstumshemmer mit anti-pept-antikörper | |
EA200200808A1 (ru) | Модифицированные цитокины, предназначенные для применения в терапии рака | |
DE60126915D1 (de) | Hybridprotease mit verringerter Antigenizität und deren Verwendung | |
EP1869468A4 (de) | Kolloidale metallkonjugate | |
TR200102988T2 (tr) | Kompleks sıvıların idare edilmesinde kullanmak için emiciler. | |
EA200400930A1 (ru) | Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний | |
MXPA03000642A (es) | Nuevos compuestos y su uso como inhibidores de transportes de glicina. | |
NZ336781A (en) | Fibronectin binding protein compositions, antibodies thereto, and methods of use | |
EA200200798A1 (ru) | Кальцилитические соединения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |